106 related articles for article (PubMed ID: 32072894)
1. Exploring the Role of Asp1116 in Selective Drug Targeting of CREBcAMP- Responsive Element-binding Protein Implicated in Prostate Cancer.
Akinsiku OE; Soremekun OS; Olotu FA; Soliman MES
Comb Chem High Throughput Screen; 2020; 23(3):178-184. PubMed ID: 32072894
[TBL] [Abstract][Full Text] [Related]
2. Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer.
Zou LJ; Xiang QP; Xue XQ; Zhang C; Li CC; Wang C; Li Q; Wang R; Wu S; Zhou YL; Zhang Y; Xu Y
Acta Pharmacol Sin; 2019 Nov; 40(11):1436-1447. PubMed ID: 31097763
[TBL] [Abstract][Full Text] [Related]
3. Development of Dimethylisoxazole-Attached Imidazo[1,2-
Muthengi A; Wimalasena VK; Yosief HO; Bikowitz MJ; Sigua LH; Wang T; Li D; Gaieb Z; Dhawan G; Liu S; Erickson J; Amaro RE; Schönbrunn E; Qi J; Zhang W
J Med Chem; 2021 May; 64(9):5787-5801. PubMed ID: 33872011
[TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer.
Xiang Q; Wang C; Zhang Y; Xue X; Song M; Zhang C; Li C; Wu C; Li K; Hui X; Zhou Y; Smaill JB; Patterson AV; Wu D; Ding K; Xu Y
Eur J Med Chem; 2018 Mar; 147():238-252. PubMed ID: 29448139
[TBL] [Abstract][Full Text] [Related]
5. Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.
Wang J; Yang ZH; Chen H; Li HH; Chen LY; Zhu Z; Zou Y; Ding CC; Yang J; He ZW
BMC Cancer; 2016 Mar; 16():257. PubMed ID: 27036119
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer.
Xiang Q; Wang C; Wu T; Zhang C; Hu Q; Luo G; Hu J; Zhuang X; Zou L; Shen H; Wu X; Zhang Y; Kong X; Liu J; Xu Y
J Med Chem; 2022 Jan; 65(1):785-810. PubMed ID: 34962793
[TBL] [Abstract][Full Text] [Related]
7. Structural insights revealed by the cocrystal structure of CCS1477 in complex with CBP bromodomain.
Xu H; Luo G; Wu T; Hu J; Wang C; Wu X; Zhang Y; Xu Y; Xiang Q
Biochem Biophys Res Commun; 2022 Oct; 623():17-22. PubMed ID: 35868068
[TBL] [Abstract][Full Text] [Related]
8. GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP).
Romero FA; Murray J; Lai KW; Tsui V; Albrecht BK; An L; Beresini MH; de Leon Boenig G; Bronner SM; Chan EW; Chen KX; Chen Z; Choo EF; Clagg K; Clark K; Crawford TD; Cyr P; de Almeida Nagata D; Gascoigne KE; Grogan JL; Hatzivassiliou G; Huang W; Hunsaker TL; Kaufman S; Koenig SG; Li R; Li Y; Liang X; Liao J; Liu W; Ly J; Maher J; Masui C; Merchant M; Ran Y; Taylor AM; Wai J; Wang F; Wei X; Yu D; Zhu BY; Zhu X; Magnuson S
J Med Chem; 2017 Nov; 60(22):9162-9183. PubMed ID: 28892380
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a potent and selective CBP bromodomain inhibitor (Y08262) for treating acute myeloid leukemia.
Xiang Q; Wu T; Zhang C; Wang C; Xu H; Hu Q; Hu J; Luo G; Zhuang X; Wu X; Zhang Y; Xu Y
Bioorg Chem; 2024 Jan; 142():106950. PubMed ID: 37924753
[TBL] [Abstract][Full Text] [Related]
10. Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis.
Jiang M; Yan Y; Yang K; Liu Z; Qi J; Zhou H; Qian N; Zhou Q; Wang T; Xu X; Xiao X; Deng L
J Cell Mol Med; 2019 Feb; 23(2):1224-1234. PubMed ID: 30461194
[TBL] [Abstract][Full Text] [Related]
11. Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.
Popp TA; Tallant C; Rogers C; Fedorov O; Brennan PE; Müller S; Knapp S; Bracher F
J Med Chem; 2016 Oct; 59(19):8889-8912. PubMed ID: 27673482
[TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery of selective BRPF1 bromodomain inhibitors.
Zhu J; Zhou C; Caflisch A
Eur J Med Chem; 2018 Jul; 155():337-352. PubMed ID: 29902720
[TBL] [Abstract][Full Text] [Related]
13. The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus.
Kim J; Jia L; Stallcup MR; Coetzee GA
J Mol Endocrinol; 2005 Feb; 34(1):107-18. PubMed ID: 15691881
[TBL] [Abstract][Full Text] [Related]
14. Acetylation of cAMP-responsive element-binding protein (CREB) by CREB-binding protein enhances CREB-dependent transcription.
Lu Q; Hutchins AE; Doyle CM; Lundblad JR; Kwok RP
J Biol Chem; 2003 May; 278(18):15727-34. PubMed ID: 12595525
[TBL] [Abstract][Full Text] [Related]
15. Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation.
Ran T; Zhang Z; Liu K; Lu Y; Li H; Xu J; Xiong X; Zhang Y; Xu A; Lu S; Liu H; Lu T; Chen Y
Mol Biosyst; 2015 May; 11(5):1295-304. PubMed ID: 25758752
[TBL] [Abstract][Full Text] [Related]
16. Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells.
Pan W; Zhang Z; Kimball H; Qu F; Berlind K; Stopsack KH; Lee GM; Choueiri TK; Kantoff PW
Clin Cancer Res; 2021 Apr; 27(7):2087-2099. PubMed ID: 33495313
[TBL] [Abstract][Full Text] [Related]
17. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1.
Frønsdal K; Engedal N; Slagsvold T; Saatcioglu F
J Biol Chem; 1998 Nov; 273(48):31853-9. PubMed ID: 9822653
[TBL] [Abstract][Full Text] [Related]
18. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.
Kumar AP; Bhaskaran S; Ganapathy M; Crosby K; Davis MD; Kochunov P; Schoolfield J; Yeh IT; Troyer DA; Ghosh R
Clin Cancer Res; 2007 May; 13(9):2784-94. PubMed ID: 17473212
[TBL] [Abstract][Full Text] [Related]
19. Theoretical research in structure characteristics of different inhibitors and differences of binding modes with CBP bromodomain.
Wang XS; Zheng QC
Bioorg Med Chem; 2018 Feb; 26(3):712-720. PubMed ID: 29329830
[TBL] [Abstract][Full Text] [Related]
20. Insights into interaction mechanism of inhibitors E3T, E3H and E3B with CREB binding protein by using molecular dynamics simulations and MM-GBSA calculations.
Wu SL; Zhao J; Sun HB; Li HY; Yin YY; Zhang LL
SAR QSAR Environ Res; 2021 Mar; 32(3):221-246. PubMed ID: 33661069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
